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Genetic Effects from Exposure to Hazardous
Agents
by Jack Favor
Mammalian germ cell stages exhibit differences in DNA synthesis activity, capability to repair DNA
damage, and chromosome-associated proteins. The sensitivity to mutation induction may be influenced by
such factors as the accessibility ofDNA to chemical mutagens, the interval between DNA damage induction
and the next round of DNA replication, and the repair of DNA damage. Such qualitative and quantitative
differences indicate the complexities ofmutation induction in vivo and emphasize that no single in vitro test
system can adequately represent the in vivo situation. Therefore, germ-cell mutagenesis in humans can most
adequately be represented by an in vivo mammalian germ-cell test system. Information regarding the
mechanisms ofmutation induction in germ cells ofthe mouse, appropriate mutation test systems available in
the mouse, as well as principles ofchemical mutagenesis in the mouse and their implications for an adequate
human genetic risk estimation will be discussed.
Introduction
The mechanism of mutation induction is a complex
processthatmayinvolvemetabolicactivation ordetoxifica-
tion ofa chemical mutagen, the induction ofDNAadducts,
and DNA repair and mutation fixation. Further,
gametogenesis in mammals is associated with cell differ-
entiation at the genetic, morphologic, and metabolic levels.
Germ cell stages exhibit differences in DNA synthesis
activity, capability to repair DNA damage, and chromo-
some-associated proteins. The sensitivity to mutation
induction may be influenced by such factors as the
accessibility of DNA to chemical mutagens, the interval
between DNA damage induction and the next round of
DNA replication, and the repair of DNA damage. Such
qualitative and quantitative differences indicate the com-
plexities ofmutation induction in vivo and emphasize that
no single in vitro test system can adequately represent
the in vivo situation. Therefore, germ-cell mutagenesis in
humans can most adequatelybe represented by an invivo
mammalian germ-cell test system. Informationregarding
the mechanisms ofmutation induction in germ cells ofthe
mouse, appropriate mutation test systems available in the
mouse, and principles of chemical mutagenesis in the
mouse and their implications for adequate human genetic
risk estimation are discussed. The discussions rely on
experimental information for gene mutations and do not
include data for chromosome structural alterations.
GSF-Institut fur Saugetiergenetik, D-8042 Neuherberg, Germany.
Molecular Characterization of
Ethyinitrosourea-Induced Mutations
To date, six independent ethylnitrosourea (ENU)-
induced mutations in germ cells of the mouse have been
characterized by direct DNA sequencing or deduced from
their amino acid substitutions (1-4; S. E. Lewis, personal
communication; J. Peters, personal communication), and
all have been shown to be base substitutions affecting an
AT site. The 06-ethylguanine adduct has been suggested
tobethemostrelevant DNAadductthatleads tomutation
(5,6). The mutation resulting from 06-ethylguanine mis-
pairing is predicted to be a GC to AT base substitution.
This predicted mechanism ofENU mutagenesis has been
experimentally confirmed inE. coli (7) and Salmonella (8),
and also predominates in Drosophila (9-11), as well as
mammalian cellsin culture (12,13). Thus, the mostrelevant
DNAadductingermcells ofthemousediffersfromthatin
other test systems. Awidevariety ofbase adducts may be
formed after the interaction of ENU with DNA (14,15).
Althoughthe06-ethylguanine adductis the mostfrequent
base ethylation thatleads tomispairing, its lackofinvolve-
mentin ENU germ-cellmutagenesis suggests an efficient
repair mechanism. In contrast, there is a lack ofevidence
for an efficient repair mechanism of O-ethyl pyrimidine
adducts, which would also lead to base mispairing (16).
Results therefore emphasize the complexities ofgerm-cell
mutagenesisinmammals and supporttheassumptionthat
the best experimental system to represent germ-cell
mutagenesisinhumansisinvivogerm-celltestsystemsin
laboratory animals.J. FAVOR
Mammalian Germ Cell Mutagenesis
Table 1 lists a number of mutation test systems devel-
oped to screen for transmitted, genetically validated
germ-cell mutations in the mouse. Avariety ofmutational
classes may be recovered by different methods, including
recessive and dominant mutations and biochemical or
immunological mutants. The methods are not mutually
exclusive, so experiments may be designed to systemat-
ically screen for more than one genetic end point in the
same experimental population (17).
The specific-locus method developed by Russell (18) is
the mostefficientmethod to screen fortransmitted germ-
cell mutations in the mouse. It has provided virtually all
experimental data on factors affecting the mutation pro-
cess in germ cells of mammals. The advantage of the
specific-locus test is that the methods to screen for muta-
tions are simple and fast, so the large numbers ofanimals
required tostudy aninfrequenteventsuch asmutation can
be examined. Finally, the animals are alive at examination
and mutations can be subjected to a genetic confirmation
test. The specific-locus method in the mouse has been
discussed in detail (19-21). For radiation, dose, dose rate,
dose fractionation, dose fractionation interval, radiation
quality, and germ-cell stage have all been shown to affect
the induced specific-locus mutation rate. For chemical
mutagens, germ-cell stage specificity plays an important
role. See the extensive reviewby Lyon (22). In contrast to
radiation where differences in the relative sensitivity to
mutation induction exist among the different sper-
matogenic stages, for chemicals, qualitative and quantita-
tive differences in the sensitivity to mutation induction
amongthe stages mayexist. Table 2illustrates thisprinci-
plefor a group ofethylating agents studied in Neuherberg
using the specific locus test. The mutagens diethyl sulfate
(DES) and ethyl methanesulfonate (EMS) are effective in
the late spermatid and early spermatozoa stages and are
not effective in spermatogonia. Methyl methanesulfonate
(MMS) has a pattern of germ-cell stage sensitivity to
mutation induction in the specific-locus test identical to
DES and EMS (23). ENU, by contrast, is mutagenically
active in post-spermatogonial stages, but mutations
mainly occur as mosaics. ENU is most effective in stem-
cell spermatogonia.
Table 1. Tests developed to detect transmitted mutations
in germ cells ofthe mouse.
Test Methods Reference
Specific locus F1, external visible traits (18)
Specific locus F1, external visible traits (40)
Recessive lethal F2 backcross, embryonic (41)
Dominant visibles F1, external visible traits (20)
Dominant skeletal F1, skeletal preparations (42,43)
Dominant cataract F1, ophthalmological (44)
examination
Dominant fitness F2, litter size effects (45)
Electrophoretic F1, variant protein (46-50)
electrophoretic pattern
Enzyme activity F1, specific enzyme (51,52)
activity
Histocompatibility F1, skin graft rejection (53)
by day 80
Table 2. Germ-cell-stage sensitivity to mutation induction
in male mice.
Intervala EMS (25) DES (54) ENU (55,56)
1-4 0/10,950 0/ 5,617
5-8 7/ 8,276 6/ 5,271 5/7,611
9-12 8/ 7,624 2/ 6,048
13-16 2/10,816 0/ 6,375 3/ 4,763
17-20 1/11,586 1/ 6,694
21-42 0/ 5,138 0/ 2,609 2/ 3,168
>43 2/28,181 0/13,551 173/58,211
Abbreviations: EMS, ethyl methanesulfonate; DES, diethyl sulfate;
ENU, ethylnitrosurea.
aInterval during which treated males were mated to untreated
females; time interval expressed as days after treatment.
Table 3. Mutagenic activity ofchemicals with conclusive specific
locus mutation test results in stem cell spermatogonia









Diethyl sulfate + -
Ethyl methanesulfonate + -





aAdapted from Ehling (57,58), Lyon, (22), and Russell (59).
Table3liststhequalitativeresultsforallchemicalswith
conclusive specific-locus mutation results in both post-
spermatogonial stages and stem-cell spermatogonia. All
possible patterns of stage sensitivity are apparent. One
group of chemicals is active in both post-spermatogonial
stages and stem-cell spermatogonia. A second group of
chemicals is active in post-spermatogonial stages but not
in stem-cell spermatogonia. Mitomycin C is not active in
post-spermatogonia but is active in stem-cell sper-
matogonia. Finally, a fourth group of chemicals is not
active in post-spermatogonial stages or in stem cell sper-
matogonia. For a complete assessment of the mutagenic
activity ofa chemical in germ cells ofmammals, all germ-
cell stages must be adequately tested (24-27). Further, a
risk assessment of a chemical mutagen must take into
accountthe germ-cell stage pattern ofmutagenic activity
as well as the mode ofexposure, chronic or acute.
Dose Response
Knowledge ofthe dose response ofa chemical mutagen
is required for an adequate estimation ofmutagenic effect
due to exposure. Otherwise, an assumption of the dose
response, usually linearity, must be invoked for a risk
estimation.
Twochemicalmutagenshavebeenextensivelystudiedin
stem-cell spermatogonia of the mouse with the specific-
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locus test: procarbazine and ENU. Results for procar-
bazineindicate ahumpeddoseresponseinwhichthereis a
dose-related increase in mutagenic response that reaches
a maximum and beyond which the mutagenic effect
decreases (28). For ENU, a threshold or quasi-thresholded
doseresponse hasbeen demonstrated (29). Thatbothdata
sets indicate nonlinear dose responses emphasizes the
difficulties in estimating genetic risk due to exposure.
These difficulties are especially pronounced if there are
large differences between the experimental dose ranges
on which extrapolation is based and the actual exposure
doseonwhichriskisestimated. Dependingontheshapeof
the dose response and the experimental dose interval
relativetothedoseforwhichriskisestimated,overestima-
tion or underestimation ofthe true risk is possible if the
extrapolation is based on the assumption oflinearity.
Relevant Genetic End Points
In a randomly mating, natural population, newly
induced recessive mutations will result in a mutant phe-
notype only when they occur as a homozygote. This is a
function ofthe square ofthe allelic frequency, and in the
firstgenerationafterradiationexposurewouldresultinan
expected negligible increase in the frequency of mutant
individuals. Dominant mutations, by definition, express
phenotypic effects as aheterozygote. Thus, newlyinduced
dominantmutationswouldbedetectedintheF1population
after radiation exposure regardless of the genotype or
matingschemeintheparentalgeneration. Table 4lists the
estimated incidence and spontaneous mutation frequency
for various classes of genetic disorders in man. The fre-
quencyofspontaneousmutationsisestimatedbasedonthe
assumption of mutation-selection equilibrium. Thus, it is
directly proportional to the selection coefficient of a
mutant allele in thepopulation and the observedincidence
of mutants. It is evident from Table 4 that in human
populations, dominant disorders have a significant inci-
dence.Alargeproportion ofdominantdisorders aredue to
newly occuring spontaneous mutations as compared to
recessive or irregularly inherited disorders and are a
major concern in estimating the genetic risk due to an
increased mutation rate. Kacser and Burns (30) have
arguedthat amutationleadingto asimpleloss orincrease
ofthenormalgenefunction shouldberecessive,whereas a
mutation leading to an alteration ofthe gene product that
interferes with the normal gene product would be domi-
nantlyexpressed.AmorelimitedspectrumofDNAaltera-
tions may result in a dominant allele rather than the
broader spectrum ofDNAlesions resultinginloss ofgene
function, which are expressed recessively. Thus, it can be
hypothesized thatthemutationaleventsleadingtoareces-
sive or a dominant allele may be qualitatively different.










Therefore, itwouldbe precarious to base all characteriza-
tions ofthe mutational process in germ cells ofmammals
on results with recessive alleles given the fact that domi-
nant alleles pose the major genetic risk and that the
mutational event leading to recessive or dominant alleles
may differ (31). For example, we have recently shown the
radiation doubling dose for induced dominant cataract
mutationstobesignificantlyhigherthanthedoublingdose
for induced recessive specific-locus mutations (32; L6bke
et al., in preparation).
Genetic Risk Estimation
Two extrapolation procedures have been developed to
estimate the genetic risk in man based on experimental
data from the mouse. The first, called the doubling dose
approach, is based on the estimate in the mouse specific-
locus test ofthe dose that results in an induced mutation
rate equal to the per-generation spontaneous mutation
rate and on an estimate ofthe spontaneous mutation rate
in humans. An indirect method to estimate the spon-
taneous mutation rate to dominant alleles in humans has
been outlined by Childs (33). Given the population inci-
dence and selection coefficient ofa dominant disorder, the
mutation rate is calculated based on the assumption of
mutation-selection equilibrium. For congenital cataract,
the population incidence is 4 x 10-5, the selection coeffi-
cientis0.3, andthespontaneousmutationrateisestimated
to be 0.6 x 10-5. For the entire class of dominant
deleterious mutations, approximately14% ofaffected indi-
viduals are estimated to be due to a newly occurring
spontaneous mutation. The number of induced dominant
genetic disorders due to mutagenic exposure in humans is
calculated as follows:
Induced cases = (Exposure dose/Doubling dose) x
Spontaneous mutation rate for dominant deleterious
mutations.
The second extrapolation procedure to estimate genetic
risk in man is called the directapproach. It is based on an
estimate ofthe induced mutation rate to dominant alleles
in mice and on an estimate of the total number of loci in
humans that result in dominant genetic disorders relative
to the number ofloci in humans controlling the indicator
phenotype used in the mouse experimental studies to
estimate the induced mutation rate (to date, skeletal and
cataract mutations). The number of induced dominant
genetic disorders due to mutagenic exposure in humans is
calculated according to Ehling (34,35) as follows:
Induced Induced mutation Totaldominantloci
cases rate per gamete X Indicator dominantloci X Dose
perdose
The direct approach avoids the problem of basing the
estimate ofinduced mutations for one genetic endpoint on
experimental mutagenesis data on a different genetic end
point. However, the estimate of the total number of loci
resulting in dominant genetic disorders and the total
numberofcataract or skeletal lociin humans is critical. It
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is based on the tabulations of dominant genetic disorders
in humans (36). The value for total dominant genetic
disorders is 1172 and for cataracts is 28. It must be
considered that this categorization is based on distinct
phenotypes with no genetic determinations that all dis-
tinctphenotypes are a result ofdistinct loci. The converse
is also possible, i.e., similar phenotypes may result from
distinct loci. Therefore, there is as yet no way to know if
these values are under- or over estimates.
It should be recalled that the sensitivity to mutation
induction bychemical mutagens in themouseis germ-cell-
stage specific. Thus, the doubling dose and induced muta-
tion rate for dominant alleles determined for a chemical
mutagen and used for an estimation ofthe genetic risk in
man is germ-cell-stage specific. For an acute exposure,
chemicals with a mutagenic effect confined to post-
spermatogonial stages will have a transitory genetic risk
confined to conceptions resulting from gametes thatwere
exposed during the sensitive stages. Conceptions occur-
ring from gametes that were exposed in the nonsensitive
stages will have a genetic risk ofzero associated with the
particularexposure. Forchemicalswith amutageniceffect
in stem-cell spermatogonia, a permanent genetic risk will
remain after an acute exposure because the stem-cell
spermatogonia population constantly cycles to reestablish
itself. For a chronic exposure, the genetic riskfor a chemi-
cal will be the combined genetic risk ofthe chemicalfor all
stages ofspermatogenesis. For chemicals with mutagenic
effects confined to post-spermatogonial stages, the
genetic risk associatedwith chronic exposurewillbeequal
to the genetic risk in the sensitive post-spermatogonial
stages regardless of the duration of exposure. Further,
upon cessation ofexposure, the genetic risk will return to
zero. For chemicals with mutagenic effects in stem-cell
spermatogonia, the genetic risk associated with chronic
exposure will constantly increase over the duration ofthe
exposure and will remain at the final level after exposure
ceases.
Thecomplete assessmentofacompoundformammalian
germ-cell mutagenesis and the associated genetic risk
would require results for treatment in female germ-cell
stages. In addition to radiation, results for the sensitivity
to induction of specific-locus mutations are only available
for four chemicals: procarbazine (37), mitomycin C (38),
triethylenemelamine (39), and ENU (37).Asformalegerm
cells, results for female germ cells indicate a germ-cell-
stage effect onthe sensitivityto mutationinduction, which
may vary depending on the mutagenic treatment used.
The dynamics ofgametogenesis infemales [seeSearle (20)
for review] include a relatively short period of mitotic
proliferation in the early embryonic stage. Meiosis is
initiated during embryogenesis and proceeds to the late
diplotene stage shortlyafter birth. Oocytes remain in this
stage until shortly before ovulation. This is the meiotic
stage ofprimaryimportanceformutagenic hazard.Within
this stage differences existin sensitivity to cell killing and
mutation induction depending onthe stage ofdevelopment
ofthe associated follicle cells. In comparison to the stem-
cell spermatogonia ofmales, theimportant stage infemale
gametogenesis maybecharacterizedbythe absence ofcell
division and DNA replication. As in stem-cell spermato-
gonia, oocytes are DNA repair competent. Thus, DNA
damage is not likely to accumulate in oocytes and there
may be a long interval between the induction of DNA
damage and the next round of DNA replication, which
occurs after fertilization.
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